News & Updates

Apremilast improves symptoms, QoL in patients with genital psoriasis
Apremilast improves symptoms, QoL in patients with genital psoriasis
15 Mar 2024 byStephen Padilla

Treatment with apremilast results in a significant reduction in genital psoriasis (G-PsO), as well as improvements in itch, pain, discomfort, redness, and quality of life (QoL), in patients with moderate-to-severe G-PsO who are intolerant to topical therapies, a study has shown.

Apremilast improves symptoms, QoL in patients with genital psoriasis
15 Mar 2024
Lockdown-induced inactivity may impair teens’ metabolic profile
Lockdown-induced inactivity may impair teens’ metabolic profile
15 Mar 2024

Forced sedentary behaviour, brought about by the COVID-19 lockdown, has negative effects on the metabolic and inflammatory profile of many teenagers, which can potentially lead to long-term poor health outcomes, suggests a study.

Lockdown-induced inactivity may impair teens’ metabolic profile
15 Mar 2024
Long COVID a driver of unemployment
Long COVID a driver of unemployment
14 Mar 2024 byAudrey Abella

Long COVID may have contributed to reduced participation in the UK labour market, a cohort study suggests.

Long COVID a driver of unemployment
14 Mar 2024